$1.24 Billion is the total value of Opti Capital Management, LP's 42 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 78.4% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
DICKS SPORTING GOODS INCnote 3.250% 4/1 | $92,431,000 | -12.0% | 29,655,000 | 0.0% | 7.44% | -6.6% | ||
Buy | CONMED CORPnote 2.625% 2/0 | $86,599,000 | +8.0% | 50,065,000 | +4.2% | 6.97% | +14.7% | |
Buy | PEGASYSTEMS INCnote 0.750% 3/0 | $64,238,000 | +75.6% | 67,730,000 | +97.9% | 5.17% | +86.3% | |
Buy | SAILPOINT TECHNOLOGIES HLDGSnote 0.125% 9/1 | $59,528,000 | +34.5% | 32,030,000 | +29.3% | 4.79% | +42.8% | |
New | DOCUSIGN INCnote 1/1 | $59,444,000 | – | 63,178,000 | +100.0% | 4.78% | – | |
Sell | WORKIVA INCnote 1.125% 8/1 | $58,863,000 | -14.9% | 36,338,000 | -6.9% | 4.74% | -9.7% | |
Buy | NEW RELIC INCnote 0.500% 5/0 | $52,879,000 | +46.9% | 52,250,000 | +74.2% | 4.26% | +55.9% | |
Buy | SUPERNUS PHARMACEUTICALSnote 0.625% 4/0 | $46,433,000 | +2.8% | 46,902,000 | +3.3% | 3.74% | +9.2% | |
Buy | 8X8 INC NEWnote 0.500% 2/0 | $44,806,000 | +9.9% | 47,575,000 | +17.3% | 3.61% | +16.7% | |
Buy | VEECO INSTRS INC DELnote 3.750% 6/0 | $44,348,000 | +9.5% | 21,000,000 | +13.5% | 3.57% | +16.2% | |
Buy | INSIGHT ENTERPRISES INCnote 0.750% 2/1 | $41,693,000 | +11.2% | 25,836,000 | +10.7% | 3.36% | +18.0% | |
New | ON SEMICONDUCTOR CORPnote 1.625%10/1 | $41,603,000 | – | 13,700,000 | +100.0% | 3.35% | – | |
Buy | ALTERYX INCnote 0.500% 8/0 | $40,422,000 | +93.6% | 43,481,000 | +96.9% | 3.25% | +105.6% | |
New | ALARM COM HLDGS INCnote 1/1 | $39,269,000 | – | 45,996,000 | +100.0% | 3.16% | – | |
Sell | IONIS PHARMACEUTICALS INCnote 0.125%12/1 | $38,559,000 | +0.5% | 42,382,000 | -0.1% | 3.10% | +6.6% | |
New | FASTLY INCnote 3/1 | $37,774,000 | – | 50,000,000 | +100.0% | 3.04% | – | |
Buy | MANDIANT INCnote 1.625% 6/0 | $36,309,000 | +15.7% | 36,309,000 | +16.0% | 2.92% | +22.8% | |
ENVESTNET INCnote 1.750% 6/0 | $36,198,000 | -4.5% | 30,000,000 | 0.0% | 2.91% | +1.4% | ||
New | BLACKLINE INCnote 3/1 | $35,940,000 | – | 42,333,000 | +100.0% | 2.89% | – | |
KBR INCnote 2.500%11/0 | $34,838,000 | +14.0% | 16,000,000 | 0.0% | 2.80% | +20.9% | ||
New | EVERBRIDGE INCnote 0.125%12/1 | $33,256,000 | – | 36,500,000 | +100.0% | 2.68% | – | |
New | COUPA SOFTWARE INCnote 0.125% 6/1 | $28,855,000 | – | 29,500,000 | +100.0% | 2.32% | – | |
ZENDESK INCnote 0.625% 6/1 | $25,346,000 | +5.8% | 20,000,000 | 0.0% | 2.04% | +12.3% | ||
Sell | AVAYA HLDGS CORPnote 2.250% 6/1 | $25,300,000 | -22.5% | 25,792,000 | -16.0% | 2.04% | -17.8% | |
Sell | NUVASIVE INCnote 1.000% 6/0 | $17,937,000 | -10.9% | 17,910,000 | -10.0% | 1.44% | -5.4% | |
Sell | NOVA LTDnote 10/1 | $15,514,000 | -67.8% | 10,000,000 | -58.8% | 1.25% | -65.9% | |
New | WIX COM LTDnote 8/1 | $13,941,000 | – | 16,012,000 | +100.0% | 1.12% | – | |
New | NEOGENOMICS INCnote 1.250% 5/0 | $13,592,000 | – | 15,750,000 | +100.0% | 1.09% | – | |
MODEL N INCnote 2.625% 6/0 | $13,321,000 | -5.2% | 12,000,000 | 0.0% | 1.07% | +0.6% | ||
HESKA CORPnote 3.750% 9/1 | $11,898,000 | -20.5% | 6,616,000 | 0.0% | 0.96% | -15.6% | ||
Sell | KARYOPHARM THERAPEUTICS INCnote 3.000%10/1 | $9,548,000 | -21.9% | 11,460,000 | -23.4% | 0.77% | -17.1% | |
PTC THERAPEUTICS INCnote 3.000% 8/1 | $8,206,000 | -3.5% | 8,000,000 | 0.0% | 0.66% | +2.5% | ||
New | NUTANIX INCnote 1/1 | $6,961,000 | – | 6,992,000 | +100.0% | 0.56% | – | |
OMEROS CORPnote 6.250%11/1 | $5,650,000 | +0.9% | 6,100,000 | 0.0% | 0.46% | +7.1% | ||
Sell | VIAVI SOLUTIONS INCnote 1.000% 3/0 | $4,040,000 | -38.0% | 3,096,000 | -32.6% | 0.32% | -34.2% | |
New | EVERBRIDGE INCnote 3/1 | $3,485,000 | – | 4,000,000 | +100.0% | 0.28% | – | |
New | THE REALREAL INCnote 3.000% 6/1 | $3,004,000 | – | 3,500,000 | +100.0% | 0.24% | – | |
New | COUPA SOFTWARE INCnote 0.375% 6/1 | $2,941,000 | – | 3,500,000 | +100.0% | 0.24% | – | |
New | WESTERN DIGITAL CORP.note 1.500% 2/0 | $2,903,000 | – | 3,000,000 | +100.0% | 0.23% | – | |
New | TWITTER INCnote 3/1 | $2,121,000 | – | 2,500,000 | +100.0% | 0.17% | – | |
New | Q2 HLDGS INCnote 0.125%11/1 | $1,300,000 | – | 1,500,000 | +100.0% | 0.10% | – | |
New | NEOGENOMICS INCnote 0.250% 1/1 | $1,003,000 | – | 1,500,000 | +100.0% | 0.08% | – | |
Exit | BIOMARIN PHARMACEUTICAL INCnote 0.599% 8/0 | $0 | – | -8,095,000 | -100.0% | -0.65% | – | |
Exit | LENDINGTREE INCnote 0.500% 7/1 | $0 | – | -11,500,000 | -100.0% | -0.73% | – | |
Exit | MANDIANT INCnote 0.875% 6/0 | $0 | – | -10,216,000 | -100.0% | -0.81% | – | |
Exit | COHERUS BIOSCIENCES INCnote 1.500% 4/1 | $0 | – | -17,650,000 | -100.0% | -1.49% | – | |
Exit | FORTIVE CORPnote 0.875% 2/1 | $0 | – | -21,927,000 | -100.0% | -1.66% | – | |
Exit | REPLIGEN CORPnote 0.375% 7/1 | $0 | – | -10,534,000 | -100.0% | -1.88% | – | |
Exit | NATIONAL VISION HLDGS INCnote 2.500% 5/1 | $0 | – | -16,591,000 | -100.0% | -2.12% | – | |
Exit | RAMBUS INC DELnote 1.375% 2/0 | $0 | – | -18,000,000 | -100.0% | -2.15% | – | |
Exit | VONAGE HLDGS CORPnote 1.750% 6/0 | $0 | – | -21,880,000 | -100.0% | -2.23% | – | |
Exit | ETSY INCnote 0.125%10/0 | $0 | – | -27,500,000 | -100.0% | -5.33% | – | |
Exit | ZSCALER INCnote 0.125% 7/0 | $0 | – | -41,140,000 | -100.0% | -6.84% | – | |
Exit | NATERA INCnote 2.250% 5/0 | $0 | – | -37,362,000 | -100.0% | -7.29% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SUPERNUS PHARMACEUTICALS INC | 14 | Q1 2023 | 6.9% |
NEW RELIC INC | 14 | Q1 2023 | 7.6% |
8X8 INC NEW | 13 | Q3 2023 | 7.4% |
MANDIANT INC | 12 | Q1 2022 | 9.9% |
NUTANIX INC | 12 | Q4 2022 | 7.3% |
OPKO HEALTH INC | 12 | Q3 2023 | 2.1% |
INSIGHT ENTERPRISES INC | 10 | Q3 2023 | 5.6% |
ALTERYX INC | 10 | Q3 2023 | 4.6% |
IONIS PHARMACEUTICALS INC | 10 | Q1 2023 | 3.6% |
MODEL N INC | 10 | Q3 2023 | 1.7% |
View Opti Capital Management, LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View Opti Capital Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.